logo-loader
viewTesla Inc

Tesla sees vehicle registration fall in China, suspends production at US factories

Tesla told shareholders it was suspending production at its Fremont, California and New York factories as the US grapples with the coronavirus outbreak

Tesla Inc -
The electric car manufacturer saw car registrations in China drop 35% in February

Tesla Inc (NASDAQ:TSLA) saw its electric car registrations in China drop sharply month-over-month in February, declining 35% according to data from LMC Automotive.

The stark drop is unsurprising given the ongoing coronavirus pandemic, which hit China starting in December.

Overall vehicle sales in the country sank 79.1% in February, its largest-ever monthly decline, according to industry data, Reuters reported Friday.

READ: Tesla tumbles as coronavirus disrupts Shanghai deliveries

In February, Tesla announced coronavirus preventive measures will hit deliveries from its new Shanghai factory. The plant is the first outside the US and is a key part of founder Elon Musk's plan to produce 500,000 cars annually.

On Thursday, Tesla also told shareholders it was suspending production at its Fremont, California and New York factories as the US grapples with the coronavirus outbreak.

In a statement, Tesla said it had US$6.3 billion in cash before a recent US$2.3 billion raise, which it says is “sufficient to successfully navigate an extended period of uncertainty.”

Tesla shares were trading around 1.5% higher on Friday morning at about US$434 each in New York.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Tesla Inc

Price: 548.84 USD

NASDAQ:TSLA
Market: NASDAQ
Market Cap: $101.2 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Algernon Pharmaceuticals receives positive feedback from...

Algernon Pharmaceuticals (CSE: AGN- OTCQB: AGNPF) CEO Christopher Moreau joined Steve Darling from Proactive Vancouver to discuss the company receiving positive feedback from Health Canada on the Company’s plan for a Phase Two COVID-19 clinical study in Canada, with its repurposed drug...

5 hours, 1 minute ago

2 min read